Wegovy, a GLP-1 weight-loss medicine, begins selling in UK pharmacies in tablet form, giving patients an alternative to injectable GLP-1 treatments. The Independent reports that the pill is the first GLP-1 option in tablet form to reach pharmacies, following approval by the UK medicines regulator last month. The Guardian describes the launch as a once-daily tablet available through high-street and online pharmacies, and frames it as a potential option for people considering weight-loss medication or switching from injections. The Mirror similarly states that the product is the UK’s first GLP-1 tablet for weight loss and positions it as replacing or supplementing weekly injection regimens. Across the reports, the emphasis is on availability—Wegovy is on sale in pharmacies now—and on format: a daily pill rather than an injection. The coverage does not provide consistent details on pricing or expected weight-loss outcomes in the supplied excerpts, focusing instead on the launch timing, the regulatory approval context, and the change from injection to oral dosing.